Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1995 Dec 1;131(5):1351–1359. doi: 10.1083/jcb.131.5.1351

Constitutive expression of calreticulin in osteoblasts inhibits mineralization

PMCID: PMC2120639  PMID: 8522595

Abstract

Recent studies have shown that the multifunctional protein calreticulin can localize to the cell nucleus and regulate gene transcription via its ability to bind a protein motif in the DNA-binding domain of nuclear hormone receptors. A number of known modulators of bone cell function, including vitamin D, act through this receptor family, suggesting that calreticulin may regulate their action in bone cells. We have used a gain-of-function strategy to examine this putative role of calreticulin in MC3T3-E1 osteoblastic cells. Purified calreticulin inhibited the binding of the vitamin D receptor to characterized vitamin D response elements in gel retardation assays. This inhibition was due to direct protein-protein interactions between the vitamin D receptor and calreticulin. Expression of calreticulin transcripts declined during MC3T3-E1 osteoblastic differentiation. MC3T3-E1 cells were transfected with calreticulin expression vectors; stably transfected cell lines overexpressing recombinant calreticulin were established and assayed for vitamin D-induced gene expression and the capacity to mineralize. Constitutive calreticulin expression inhibited basal and vitamin D-induced expression of the osteocalcin gene, whereas osteopontin gene expression was unaffected. This pattern mimicked the gene expression pattern observed in parental cells before down- regulation of endogenous calreticulin expression. In long-term cultures of parental or vector-transfected cells, 1 alpha,25-dihydroxyvitamin D3 (1,25[OH]2D3) induced a two- to threefold stimulation of 45Ca accumulation into the matrix layer. Constitutive expression of calreticulin inhibited the 1,25(OH)2D3-induced 45Ca accumulation. This result correlated with the complete absence of mineralization nodules in long-term cultures of calreticulin-transfected cells. These data suggest that calreticulin can regulate bone cell function by interacting with specific nuclear hormone receptor-mediated pathways.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auffray C., Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980 Jun;107(2):303–314. doi: 10.1111/j.1432-1033.1980.tb06030.x. [DOI] [PubMed] [Google Scholar]
  2. Burns K., Duggan B., Atkinson E. A., Famulski K. S., Nemer M., Bleackley R. C., Michalak M. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature. 1994 Feb 3;367(6462):476–480. doi: 10.1038/367476a0. [DOI] [PubMed] [Google Scholar]
  3. Candeliere G. A., Prud'homme J., St-Arnaud R. Differential stimulation of fos and jun family members by calcitriol in osteoblastic cells. Mol Endocrinol. 1991 Dec;5(12):1780–1788. doi: 10.1210/mend-5-12-1780. [DOI] [PubMed] [Google Scholar]
  4. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L. J., Grippo J. F., Hunziker W. Two nuclear signalling pathways for vitamin D. Nature. 1993 Feb 18;361(6413):657–660. doi: 10.1038/361657a0. [DOI] [PubMed] [Google Scholar]
  5. Celeste A. J., Rosen V., Buecker J. L., Kriz R., Wang E. A., Wozney J. M. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J. 1986 Aug;5(8):1885–1890. doi: 10.1002/j.1460-2075.1986.tb04440.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dedhar S. Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem Sci. 1994 Jul;19(7):269–271. doi: 10.1016/0968-0004(94)90001-9. [DOI] [PubMed] [Google Scholar]
  7. Dedhar S., Rennie P. S., Shago M., Hagesteijn C. Y., Yang H., Filmus J., Hawley R. G., Bruchovsky N., Cheng H., Matusik R. J. Inhibition of nuclear hormone receptor activity by calreticulin. Nature. 1994 Feb 3;367(6462):480–483. doi: 10.1038/367480a0. [DOI] [PubMed] [Google Scholar]
  8. Dedhar S. Signal transduction via the beta 1 integrins is a required intermediate in interleukin-1 beta induction of alkaline phosphatase activity in human osteosarcoma cells. Exp Cell Res. 1989 Jul;183(1):207–214. doi: 10.1016/0014-4827(89)90430-8. [DOI] [PubMed] [Google Scholar]
  9. Demay M. B., Gerardi J. M., DeLuca H. F., Kronenberg H. M. DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1990 Jan;87(1):369–373. doi: 10.1073/pnas.87.1.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Demay M. B., Roth D. A., Kronenberg H. M. Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 on gene transcription. J Biol Chem. 1989 Feb 5;264(4):2279–2282. [PubMed] [Google Scholar]
  11. Ecarot-Charrier B., Glorieux F. H., van der Rest M., Pereira G. Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol. 1983 Mar;96(3):639–643. doi: 10.1083/jcb.96.3.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ellis L., Clauser E., Morgan D. O., Edery M., Roth R. A., Rutter W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 1986 Jun 6;45(5):721–732. doi: 10.1016/0092-8674(86)90786-5. [DOI] [PubMed] [Google Scholar]
  13. Eriksen E. F., Colvard D. S., Berg N. J., Graham M. L., Mann K. G., Spelsberg T. C., Riggs B. L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988 Jul 1;241(4861):84–86. doi: 10.1126/science.3388021. [DOI] [PubMed] [Google Scholar]
  14. Fuller P. J. The steroid receptor superfamily: mechanisms of diversity. FASEB J. 1991 Dec;5(15):3092–3099. doi: 10.1096/fasebj.5.15.1743440. [DOI] [PubMed] [Google Scholar]
  15. Glass C. K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994 Jun;15(3):391–407. doi: 10.1210/edrv-15-3-391. [DOI] [PubMed] [Google Scholar]
  16. Heath J. K., Rodan S. B., Yoon K., Rodan G. A. Rat calvarial cell lines immortalized with SV-40 large T antigen: constitutive and retinoic acid-inducible expression of osteoblastic features. Endocrinology. 1989 Jun;124(6):3060–3068. doi: 10.1210/endo-124-6-3060. [DOI] [PubMed] [Google Scholar]
  17. Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M., Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992 Jan 24;68(2):397–406. doi: 10.1016/0092-8674(92)90479-v. [DOI] [PubMed] [Google Scholar]
  18. Hughes-Fulford M., Appel R., Kumegawa M., Schmidt J. Effect of dexamethasone on proliferating osteoblasts: inhibition of prostaglandin E2 synthesis, DNA synthesis, and alterations in actin cytoskeleton. Exp Cell Res. 1992 Nov;203(1):150–156. doi: 10.1016/0014-4827(92)90050-i. [DOI] [PubMed] [Google Scholar]
  19. Hughes D. E., Salter D. M., Dedhar S., Simpson R. Integrin expression in human bone. J Bone Miner Res. 1993 May;8(5):527–533. doi: 10.1002/jbmr.5650080503. [DOI] [PubMed] [Google Scholar]
  20. Kerner S. A., Scott R. A., Pike J. W. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4455–4459. doi: 10.1073/pnas.86.12.4455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kliewer S. A., Umesono K., Mangelsdorf D. J., Evans R. M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 Jan 30;355(6359):446–449. doi: 10.1038/355446a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kurihara N., Ishizuka S., Kiyoki M., Haketa Y., Ikeda K., Kumegawa M. Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology. 1986 Mar;118(3):940–947. doi: 10.1210/endo-118-3-940. [DOI] [PubMed] [Google Scholar]
  23. Lemischka I. R., Farmer S., Racaniello V. R., Sharp P. A. Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol. 1981 Sep 5;151(1):101–120. doi: 10.1016/0022-2836(81)90223-0. [DOI] [PubMed] [Google Scholar]
  24. Leung-Hagesteijn C. Y., Milankov K., Michalak M., Wilkins J., Dedhar S. Cell attachment to extracellular matrix substrates is inhibited upon downregulation of expression of calreticulin, an intracellular integrin alpha-subunit-binding protein. J Cell Sci. 1994 Mar;107(Pt 3):589–600. [PubMed] [Google Scholar]
  25. Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 1992 Jan 23;355(6358):359–361. doi: 10.1038/355359a0. [DOI] [PubMed] [Google Scholar]
  26. Lieu T. S., Newkirk M. M., Capra J. D., Sontheimer R. D. Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J Clin Invest. 1988 Jul;82(1):96–101. doi: 10.1172/JCI113607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. MacDonald P. N., Haussler C. A., Terpening C. M., Galligan M. A., Reeder M. C., Whitfield G. K., Haussler M. R. Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor. J Biol Chem. 1991 Oct 5;266(28):18808–18813. [PubMed] [Google Scholar]
  28. Mahonen A., Pirskanen A., Keinänen R., Mäenpä P. H. Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim Biophys Acta. 1990 Jan 30;1048(1):30–37. doi: 10.1016/0167-4781(90)90018-w. [DOI] [PubMed] [Google Scholar]
  29. Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A., Evans R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992 Mar;6(3):329–344. doi: 10.1101/gad.6.3.329. [DOI] [PubMed] [Google Scholar]
  30. Matsumoto T., Igarashi C., Takeuchi Y., Harada S., Kikuchi T., Yamato H., Ogata E. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells. Bone. 1991;12(1):27–32. doi: 10.1016/8756-3282(91)90051-j. [DOI] [PubMed] [Google Scholar]
  31. McCauliffe D. P., Yang Y. S., Wilson J., Sontheimer R. D., Capra J. D. The 5'-flanking region of the human calreticulin gene shares homology with the human GRP78, GRP94, and protein disulfide isomerase promoters. J Biol Chem. 1992 Feb 5;267(4):2557–2562. [PubMed] [Google Scholar]
  32. Michalak M., Milner R. E., Burns K., Opas M. Calreticulin. Biochem J. 1992 Aug 1;285(Pt 3):681–692. doi: 10.1042/bj2850681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Miyazaki Y., Setoguchi M., Yoshida S., Higuchi Y., Akizuki S., Yamamoto S. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem. 1990 Aug 25;265(24):14432–14438. [PubMed] [Google Scholar]
  34. Nakayama H., Ichikawa F., Andres J. L., Massagué J., Noda M. Dexamethasone enhancement of betaglycan (TGF-beta type III receptor) gene expression in osteoblast-like cells. Exp Cell Res. 1994 Apr;211(2):301–306. doi: 10.1006/excr.1994.1091. [DOI] [PubMed] [Google Scholar]
  35. Ng K. W., Gummer P. R., Michelangeli V. P., Bateman J. F., Mascara T., Cole W. G., Martin T. J. Regulation of alkaline phosphatase expression in a neonatal rat clonal calvarial cell strain by retinoic acid. J Bone Miner Res. 1988 Feb;3(1):53–61. doi: 10.1002/jbmr.5650030109. [DOI] [PubMed] [Google Scholar]
  36. Nishikawa J., Matsumoto M., Sakoda K., Kitaura M., Imagawa M., Nishihara T. Vitamin D receptor zinc finger region binds to a direct repeat as a dimer and discriminates the spacing number between each half-site. J Biol Chem. 1993 Sep 15;268(26):19739–19743. [PubMed] [Google Scholar]
  37. Noda M., Vogel R. L., Craig A. M., Prahl J., DeLuca H. F., Denhardt D. T. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9995–9999. doi: 10.1073/pnas.87.24.9995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Norman A. W., Nemere I., Zhou L. X., Bishop J. E., Lowe K. E., Maiyar A. C., Collins E. D., Taoka T., Sergeev I., Farach-Carson M. C. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):231–240. doi: 10.1016/0960-0760(92)90349-n. [DOI] [PubMed] [Google Scholar]
  39. Opas M., Dziak E., Fliegel L., Michalak M. Regulation of expression and intracellular distribution of calreticulin, a major calcium binding protein of nonmuscle cells. J Cell Physiol. 1991 Oct;149(1):160–171. doi: 10.1002/jcp.1041490120. [DOI] [PubMed] [Google Scholar]
  40. Ostwald T. J., MacLennan D. H. Isolation of a high affinity calcium-binding protein from sarcoplasmic reticulum. J Biol Chem. 1974 Feb 10;249(3):974–979. [PubMed] [Google Scholar]
  41. Ozono K., Sone T., Pike J. W. The genomic mechanism of action of 1,25-dihydroxyvitamin D3. J Bone Miner Res. 1991 Oct;6(10):1021–1027. doi: 10.1002/jbmr.5650061002. [DOI] [PubMed] [Google Scholar]
  42. Rahman S., Oberdorf A., Montecino M., Tanhauser S. M., Lian J. B., Stein G. S., Laipis P. J., Stein J. L. Multiple copies of the bone-specific osteocalcin gene in mouse and rat. Endocrinology. 1993 Dec;133(6):3050–3053. doi: 10.1210/endo.133.6.8243336. [DOI] [PubMed] [Google Scholar]
  43. Rojiani M. V., Finlay B. B., Gray V., Dedhar S. In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin alpha subunits. Biochemistry. 1991 Oct 15;30(41):9859–9866. doi: 10.1021/bi00105a008. [DOI] [PubMed] [Google Scholar]
  44. Rokeach L. A., Haselby J. A., Hoch S. O. High-level bacterial expression, purification and characterization of human calreticulin. Protein Eng. 1991 Dec;4(8):981–987. doi: 10.1093/protein/4.8.981. [DOI] [PubMed] [Google Scholar]
  45. Rudnicki M. A., Braun T., Hinuma S., Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 1992 Oct 30;71(3):383–390. doi: 10.1016/0092-8674(92)90508-a. [DOI] [PubMed] [Google Scholar]
  46. Saito T., Albelda S. M., Brighton C. T. Identification of integrin receptors on cultured human bone cells. J Orthop Res. 1994 May;12(3):384–394. doi: 10.1002/jor.1100120311. [DOI] [PubMed] [Google Scholar]
  47. Smith J. H., Denhardt D. T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem. 1987 May;34(1):13–22. doi: 10.1002/jcb.240340103. [DOI] [PubMed] [Google Scholar]
  48. St-Arnaud R., Moir J. M. Wnt-1-inducing factor-1: a novel G/C box-binding transcription factor regulating the expression of Wnt-1 during neuroectodermal differentiation. Mol Cell Biol. 1993 Mar;13(3):1590–1598. doi: 10.1128/mcb.13.3.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. St-Arnaud R., Nepveu A., Marcu K. B., McBurney M. W. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells. Oncogene. 1988 Nov;3(5):553–559. [PubMed] [Google Scholar]
  50. Stein G. S., Lian J. B., Owen T. A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 1990 Oct;4(13):3111–3123. doi: 10.1096/fasebj.4.13.2210157. [DOI] [PubMed] [Google Scholar]
  51. Sudo H., Kodama H. A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983 Jan;96(1):191–198. doi: 10.1083/jcb.96.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Traianedes K., Ng K. W., Martin T. J., Findlay D. M. Cell substratum modulates responses of preosteoblasts to retinoic acid. J Cell Physiol. 1993 Nov;157(2):243–252. doi: 10.1002/jcp.1041570206. [DOI] [PubMed] [Google Scholar]
  53. Vukicevic S., Luyten F. P., Kleinman H. K., Reddi A. H. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell. 1990 Oct 19;63(2):437–445. doi: 10.1016/0092-8674(90)90176-f. [DOI] [PubMed] [Google Scholar]
  54. Wheeler D. G., Horsford J., Michalak M., White J. H., Hendy G. N. Calreticulin inhibits vitamin D3 signal transduction. Nucleic Acids Res. 1995 Aug 25;23(16):3268–3274. doi: 10.1093/nar/23.16.3268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yoon K. G., Rutledge S. J., Buenaga R. F., Rodan G. A. Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3. Biochemistry. 1988 Nov 15;27(23):8521–8526. doi: 10.1021/bi00423a003. [DOI] [PubMed] [Google Scholar]
  56. Yu V. C., Delsert C., Andersen B., Holloway J. M., Devary O. V., När A. M., Kim S. Y., Boutin J. M., Glass C. K., Rosenfeld M. G. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 1991 Dec 20;67(6):1251–1266. doi: 10.1016/0092-8674(91)90301-e. [DOI] [PubMed] [Google Scholar]
  57. Zhou H., Choong P., McCarthy R., Chou S. T., Martin T. J., Ng K. W. In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res. 1994 Sep;9(9):1489–1499. doi: 10.1002/jbmr.5650090922. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES